Last news
Chance Pharmaceuticals and Acorda Therapeutics Announce Agreement to Provide INBRIJA® in Greater China

Chance Pharmaceuticals and Acorda Therapeutics Announce Agreement to Provide INBRIJA® in Greater China

...

Eagle Ford Shale Asset Opportunity - The VirTex Companies

Eagle Ford Shale Asset Opportunity - The VirTex Companies

...

Hummingbird Bioscience to Present Preclinical Proof of Concept for Potentially First-In-Class Antibody Targeting Autoimmune Diseases

Hummingbird Bioscience to Present Preclinical Proof of Concept for Potentially First-In-Class Antibody Targeting Autoimmune Diseases

...

Tencent Cloud Ranked First in China Video Cloud Solution Market for Five Consecutive Years

Tencent Cloud Ranked First in China Video Cloud Solution Market for Five Consecutive Years

...

LONGi looks to create a strong voice across the globe in pursuit of a sustainable green, low-carbon lifestyle

LONGi looks to create a strong voice across the globe in pursuit of a sustainable green, low-carbon lifestyle

...

mōziware and TeamViewer Join Forces to Offer Integrated AR Digital Solutions Globally

mōziware and TeamViewer Join Forces to Offer Integrated AR Digital Solutions Globally

...

ONEUS 9th Mini Album 'PYGMALION' Releases Today (May 8 KST)! A New 5-Member Group… Return of the 'Iconic 4th Generation Performers'!

ONEUS 9th Mini Album 'PYGMALION' Releases Today (May 8 KST)! A New 5-Member Group… Return of the 'Iconic 4th Generation Performers'!

...

Ascletis Announces China NMPA Approval of Conducting a Phase IIa Clinical Trial for ASC10 to Treat Respiratory Syncytial Virus Infection

Ascletis Announces China NMPA Approval of Conducting a Phase IIa Clinical Trial for ASC10 to Treat Respiratory Syncytial Virus Infection

...

menu
menu